Olivia Putri Chairunnisa, Mia Audina, and Irawati , trans. 2025. “Which Anti-VEGF Therapy (Ranibizumab, Bevacizumab, or Aflibercept) Demonstrates The Most Cost-Effective Outcomes For Treating Age-Related Macular Degeneration ? : A Systematic Review”. The Indonesian Journal of General Medicine 12 (3): 1-48. https://doi.org/10.70070/vbsedq58.